Home
HelpTest ID BLOD1106 Leflunomide Metabolite (Teriflunomide), Serum
Useful For
Therapeutic monitoring of patients actively taking leflunomide
Assessment of elimination in patients requiring enhanced elimination of the drug
Specimen Type
Serum RedSpecimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Draw blood no sooner than 12 hours (trough value) after last dose.
2. Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.3 mL
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | OK |
| Gross icterus | OK |
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum Red | Ambient (preferred) | 28 days | |
| Frozen | 28 days | ||
| Refrigerated | 28 days |
Day(s) Performed
Monday, Wednesday, Friday
Report Available
3 to 5 daysMethod Name
High-Turbulence Liquid Chromatography Mass Spectrometry (HTLC-MS/MS)
Performing Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
80193
Reporting Name
Leflunomide Metabolite, SReference Values
Therapeutic: >40 mcg/mL
Elimination: <0.020 mcg/mL
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
Secondary ID
60292SANFORD INTERFACE BUILD INFORMATION
| Result Code | Result Code Description |
|---|---|
| 13067 | Leflunomide Metabolite, S |